Evolus Appoints New Directors, One Departs
Ticker: EOLS · Form: 8-K · Filed: May 27, 2025 · CIK: 1570562
Sentiment: neutral
Topics: board-changes, governance, director-election
Related Tickers: EVOL
TL;DR
Evolus board shakeup: Dr. Brown out, Blount & Griffin in.
AI Summary
Evolus, Inc. announced on May 23, 2025, the departure of director Dr. David L. Brown. The company also elected two new directors, Dr. Jeffrey L. Blount and Ms. Michelle L. Griffin, to its board. These changes are effective immediately.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future decision-making.
Risk Assessment
Risk Level: low — The filing reports routine board changes and director elections, which are common corporate governance events.
Key Players & Entities
- Evolus, Inc. (company) — Registrant
- Dr. David L. Brown (person) — Departing Director
- Dr. Jeffrey L. Blount (person) — Newly Elected Director
- Ms. Michelle L. Griffin (person) — Newly Elected Director
- May 23, 2025 (date) — Effective date of changes
FAQ
Who has departed from the Evolus, Inc. board of directors?
Dr. David L. Brown has departed from the Evolus, Inc. board of directors.
Who has been elected as new directors to the Evolus, Inc. board?
Dr. Jeffrey L. Blount and Ms. Michelle L. Griffin have been elected as new directors.
What is the effective date of these board changes?
The changes are effective as of May 23, 2025.
What is the exact name of the company filing this report?
The exact name of the company is Evolus, Inc.
In which state was Evolus, Inc. incorporated?
Evolus, Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 27, 2025 by Dr. David L. Brown regarding Evolus, Inc. (EOLS).